Arrowhead Pharmaceuticals Inc (0HI3)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31.41M | 16.14M | 168.8M | 87.99M | 138.29M | 243.23M | 240.74M | 3.55M |
| Operating Income | -37M | -55.94M | 61.19M | -93.16M | -149.04M | -178.51M | -205M | -601.08M |
| Pre Tax Income | -34.38M | -54.45M | 68.15M | -84.55M | -140.85M | -172.71M | -206.49M | -612.46M |
| Net Income | -34.38M | -54.45M | 67.98M | -84.55M | -140.85M | -176.06M | -205.28M | -599.49M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.46 | -0.615 | 0.712 | -0.826 | -1.35 | -1.661 | -1.915 | -4.822 |
| EBIT | -35.68M | -55.93M | 61.19M | -93.74M | -146.97M | -177.74M | -203.46M | -602.83M |
| EBITDA | -32.31M | -51.24M | 65.63M | -87.22M | -140.77M | -168.09M | -192.51M | -582.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
